株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

注入型ドラッグデリバリーの世界市場:分析と傾向 - 産業動向の予測

Global Injectable Drug Delivery Market Analysis & Trends - Industry Forecast to 2027

発行 Accuray Research 商品コード 590966
出版日 ページ情報 英文 195 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.06円で換算しております。
Back to Top
注入型ドラッグデリバリーの世界市場:分析と傾向 - 産業動向の予測 Global Injectable Drug Delivery Market Analysis & Trends - Industry Forecast to 2027
出版日: 2018年10月01日 ページ情報: 英文 195 Pages
概要

当レポートでは、世界の注入型ドラッグデリバリー (薬剤送達) の市場について分析し、市場の概要や最新情勢、主な市場促進・抑制要因、市場規模の動向見通し (過去3年間・今後10年間分)、容器別・利用パターン別・種類別 (デバイス/剤型)・投与箇所別・流通チャネル別・用途別・地域別の詳細動向、近年の資本取引・事業戦略の動き、主要企業のプロファイルなどを調査しております。

第1章 分析概略

第2章 エグゼクティブ・サマリー

第3章 市場概要

  • 目下の動向
  • 市場促進要因
  • 市場抑制要因
  • 業界の求心力:ポーターのファイブフォース分析

第4章 注入型ドラッグデリバリー市場:剤型容器別

  • バイアル
  • ボトル (瓶)
  • カートリッジ
  • アンプル

第5章 注入型ドラッグデリバリー市場:利用パターン別

  • 予防接種
  • 疾患治療
  • その他

第6章 注入型ドラッグデリバリー市場:種類別

  • 剤型
  • デバイス

第7章 注入型ドラッグデリバリー市場:投与箇所別

  • 人体組織
  • 皮膚
  • 中枢神経系 (CNS)
  • 循環系/筋骨格系

第8章 注入型ドラッグデリバリー市場:流通チャネル別

  • 小売薬局
  • 院内薬局
  • オンライン薬局
  • 直接受注

第9章 注入型ドラッグデリバリー市場:用途別

  • 奇病
  • 腫瘍
  • 自己免疫疾患
  • ホルモン障害
  • その他の用途

第10章 注入型ドラッグデリバリー市場:エンドユーザー別

  • 在宅治療
  • 病院・クリニック
  • 製薬企業/バイオテクノロジー企業
  • 研究所
  • その他のエンドユーザー

第11章 獣医用イメージング装置市場:地域別

  • 北米市場 (米国、カナダ、メキシコ)
  • 欧州市場 (ドイツ、英国、イタリア、フランス、スペインなど)
  • アジア太平洋地域市場 (中国、日本、インド、オーストラリア、ニュージーランドなど)
  • 中東市場 (サウジアラビア、UAEなど)
  • 他の国々 (RoW:南アフリカなど)
  • ラテンアメリカ市場 (アルゼンチン、ブラジルなど)

第12章 主要企業の活動状況

  • 企業合併・買収 (M&A)
  • 合意、事業提携/協力、合弁事業
  • 製品発売・事業拡張
  • その他の活動

第13章 代表的企業

  • Gerresheimer AG
  • Baxter International, Inc.
  • Pfizer, Inc.
  • Alkermes Plc.
  • Becton Dickinson and Company
  • Eli Lilly and Company
  • Schott AG
  • Sandoz
  • Teva Pharmaceuticals Industries Ltd.
  • Bespak
  • Ypsomed
  • テルモ
  • Elcam Medical
  • Unilife Corporation
  • Endocyte
  • Genentech Inc.
  • BIND Biosciences Inc.
図表

List of Tables

  • Table 1: Global Injectable Drug Delivery Market By Region, Market Forecast(2015-2027)(US $MN)
  • Table 2: Global Injectable Drug Delivery Market By Formulation Packaging, Market Forecast(2015-2027)(US $MN)
  • Table 3: Global Injectable Drug Delivery Market By Vials, Market Forecast(2015-2027)(US $MN)
  • Table 4: Global Injectable Drug Delivery Market By Bottles, Market Forecast(2015-2027)(US $MN)
  • Table 5: Global Injectable Drug Delivery Market By Cartridges, Market Forecast(2015-2027)(US $MN)
  • Table 6: Global Injectable Drug Delivery Market By Ampules, Market Forecast(2015-2027)(US $MN)
  • Table 7: Global Injectable Drug Delivery Market By Usage Pattern, Market Forecast(2015-2027)(US $MN)
  • Table 8: Global Injectable Drug Delivery Market By Immunization, Market Forecast(2015-2027)(US $MN)
  • Table 9: Global Injectable Drug Delivery Market By Curative Care, Market Forecast(2015-2027)(US $MN)
  • Table 10: Global Injectable Drug Delivery Market By Other Usage Patterns, Market Forecast(2015-2027)(US $MN)
  • Table 11: Global Injectable Drug Delivery Market By Type, Market Forecast(2015-2027)(US $MN)
  • Table 12: Global Injectable Drug Delivery Market By Formulation, Market Forecast(2015-2027)(US $MN)
  • Table 13: Global Injectable Drug Delivery Market By Novel Drug Delivery Formulations, Market Forecast(2015-2027)(US $MN)
  • Table 14: Global Injectable Drug Delivery Market By Conventional Drug Delivery Formulations, Market Forecast(2015-2027)(US $MN)
  • Table 15: Global Injectable Drug Delivery Market By Device, Market Forecast(2015-2027)(US $MN)
  • Table 16: Global Injectable Drug Delivery Market By Self Injection Devices, Market Forecast(2015-2027)(US $MN)
  • Table 17: Global Injectable Drug Delivery Market By Conventional Injection Devices, Market Forecast(2015-2027)(US $MN)
  • Table 18: Global Injectable Drug Delivery Market By Site Of Administration, Market Forecast(2015-2027)(US $MN)
  • Table 19: Global Injectable Drug Delivery Market By Organs, Market Forecast(2015-2027)(US $MN)
  • Table 20: Global Injectable Drug Delivery Market By Skin, Market Forecast(2015-2027)(US $MN)
  • Table 21: Global Injectable Drug Delivery Market By Central Nervous System, Market Forecast(2015-2027)(US $MN)
  • Table 22: Global Injectable Drug Delivery Market By Circulatory/Musculoskeletal System, Market Forecast(2015-2027)(US $MN)
  • Table 23: Global Injectable Drug Delivery Market By Distribution Channel, Market Forecast(2015-2027)(US $MN)
  • Table 24: Global Injectable Drug Delivery Market By Pharmacy Stores, Market Forecast(2015-2027)(US $MN)
  • Table 25: Global Injectable Drug Delivery Market By Hospital Pharmacy, Market Forecast(2015-2027)(US $MN)
  • Table 26: Global Injectable Drug Delivery Market By Online Pharmacy, Market Forecast(2015-2027)(US $MN)
  • Table 27: Global Injectable Drug Delivery Market By Direct Tender, Market Forecast(2015-2027)(US $MN)
  • Table 28: Global Injectable Drug Delivery Market By Application, Market Forecast(2015-2027)(US $MN)
  • Table 29: Global Injectable Drug Delivery Market By Orphan Disease, Market Forecast(2015-2027)(US $MN)
  • Table 30: Global Injectable Drug Delivery Market By Oncology, Market Forecast(2015-2027)(US $MN)
  • Table 31: Global Injectable Drug Delivery Market By Autoimmune Diseases, Market Forecast(2015-2027)(US $MN)
  • Table 32: Global Injectable Drug Delivery Market By Rheumatoid Arthritis, Market Forecast(2015-2027)(US $MN)
  • Table 33: Global Injectable Drug Delivery Market By Multiple Sclerosis, Market Forecast(2015-2027)(US $MN)
  • Table 34: Global Injectable Drug Delivery Market By Crohn'S Diseases, Market Forecast(2015-2027)(US $MN)
  • Table 35: Global Injectable Drug Delivery Market By Psoriasis, Market Forecast(2015-2027)(US $MN)
  • Table 36: Global Injectable Drug Delivery Market By Other Autoimmune Diseases, Market Forecast(2015-2027)(US $MN)
  • Table 37: Global Injectable Drug Delivery Market By Hormonal Disorder, Market Forecast(2015-2027)(US $MN)
  • Table 38: Global Injectable Drug Delivery Market By Anemia, Market Forecast(2015-2027)(US $MN)
  • Table 39: Global Injectable Drug Delivery Market By Reproductive Health Disease, Market Forecast(2015-2027)(US $MN)
  • Table 40: Global Injectable Drug Delivery Market By Antithrombotic/Thrombolytic Therapy, Market Forecast(2015-2027)(US $MN)
  • Table 41: Global Injectable Drug Delivery Market By Osteoporosis, Market Forecast(2015-2027)(US $MN)
  • Table 42: Global Injectable Drug Delivery Market By Growth Hormone Disorders(GHD), Market Forecast(2015-2027)(US $MN)
  • Table 43: Global Injectable Drug Delivery Market By Other Applications, Market Forecast(2015-2027)(US $MN)
  • Table 44: Global Injectable Drug Delivery Market By Pain Management, Market Forecast(2015-2027)(US $MN)
  • Table 45: Global Injectable Drug Delivery Market By Allergy Treatment, Market Forecast(2015-2027)(US $MN)
  • Table 46: Global Injectable Drug Delivery Market By Aesthetic Treatments, Market Forecast(2015-2027)(US $MN)
  • Table 47: Global Injectable Drug Delivery Market By Hepatitis C, Market Forecast(2015-2027)(US $MN)
  • Table 48: Global Injectable Drug Delivery Market By Hemophilia, Market Forecast(2015-2027)(US $MN)
  • Table 49: Global Injectable Drug Delivery Market By End User, Market Forecast(2015-2027)(US $MN)
  • Table 50: Global Injectable Drug Delivery Market By Home Healthcare Settings, Market Forecast(2015-2027)(US $MN)
  • Table 51: Global Injectable Drug Delivery Market By Hospitals And Clinics, Market Forecast(2015-2027)(US $MN)
  • Table 52: Global Injectable Drug Delivery Market By Pharmaceutical & Biotechnological Companies, Market Forecast(2015-2027)(US $MN)
  • Table 53: Global Injectable Drug Delivery Market By Research Laboratories, Market Forecast(2015-2027)(US $MN)
  • Table 54: Global Injectable Drug Delivery Market By Other End Users, Market Forecast(2015-2027)(US $MN)

Note: North America, Europe, Asia Pacific, Middle East, Latin America and RoW tables are represented in above manner.

目次

The Global Injectable Drug Delivery Market is poised to grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing includerising demand for injectable drug delivery in biologics market, rising demand for biosimilars and increasing demand for adoption of self-injection devices.

By formulation packaging, the market is divided into vials, bottles, cartridges and ampules. Based on the usage pattern, the market is classified into immunization, curative care and other usage patterns.

By type, the market is segmented into formulation and device. Formulation segment is further segmented into novel drug delivery formulations and conventional drug delivery formulations. The device segment is sub segmented into self injection devices and conventional injection devices. The novel drug delivery formulations are further classified into long acting injection formulation, microparticles and colloidal dispersions. The conventional drug delivery formulations are further segregated into suspensions, solutions, reconstituted/lyophilized formulations and emulsions. In addition, the self injection devices are further divided into needle free injectors (NFI), wearable injectors, pen injectors, auto injectors and other devices. The conventional injection devices are further segmented into product, material and usability.

Considering the site of administration, the market is split into organs, skin, central nervous system and circulatory/musculoskeletal system. By distribution channel, the market is bifurcated into pharmacy stores, hospital pharmacy, online pharmacy and direct tender.

Based on application, the market is fragmented into orphan disease, oncology, autoimmune diseases, hormonal disorder and other applications. Autoimmune diseases are further segregated into rheumatoid arthritis, multiple sclerosis, crohn's diseases, psoriasis and other autoimmune diseases. Whereas, the hormonal disorders are further classified into Anemia, reproductive health disease, antithrombotic/thrombolytic therapy, osteoporosis and growth hormone disorders (GHD). Moreover, the other applications segment are sub segmented into pain management, allergy treatment, aesthetic treatments, hepatitis C and haemophilia.

By end user, the market is segmented into home healthcare settings, hospitals and clinics, pharmaceutical & biotechnological companies, research laboratories and other end users.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America

  • US
  • Canada
  • Mexico

Europe

  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific

Middle East

  • Saudi Arabia
  • UAE
  • Rest of Middle East

Latin America

  • Argentina
  • Brazil
  • Rest of Latin America

Rest of the World

  • South Africa
  • Others

Report Highlights:

  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2027, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2027
  • Market opportunities and recommendations for new investments

Table of Contents

1. Market Outline

  • 1.1. Research Methodology
    • 1.1.1. Research Approach & Sources
  • 1.2. Market Trends
  • 1.3. Regulatory Factors
  • 1.4. Application Analysis
  • 1.5. End User Analysis
  • 1.6. Strategic Benchmarking
  • 1.7. Opportunity Analysis

2. Executive Summary

3. Market Overview

  • 3.1. Current Trends
    • 3.1.1. Rising Demand for Injectable Drug Delivery in Biologics Market
    • 3.1.2. Rising Demand for Biosimilars
    • 3.1.3. Increasing Demand for Adoption of Self-Injection Devices
    • 3.1.4. Growth Opportunities/Investment Opportunities
  • 3.2. Drivers
  • 3.3. Constraints
  • 3.4. Industry Attractiveness
    • 3.4.1. Bargaining power of suppliers
    • 3.4.2. Bargaining power of buyers
    • 3.4.3. Threat of substitutes
    • 3.4.4. Threat of new entrants
    • 3.4.5. Competitive rivalry

4. Injectable Drug Delivery Market, By Formulation Packaging

  • 4.1. Vials
    • DATA TABLE: Vials Market Forecast to 2027(US$ MN)
  • 4.2. Bottles
    • DATA TABLE: Bottles Market Forecast to 2027(US$ MN)
  • 4.3. Cartridges
    • DATA TABLE: Cartridges Market Forecast to 2027(US$ MN)
  • 4.4. Ampules
    • DATA TABLE: Ampules Market Forecast to 2027(US$ MN)

5. Injectable Drug Delivery Market, By Usage Pattern

  • 5.1. Immunization
    • DATA TABLE: Immunization Market Forecast to 2027(US$ MN)
  • 5.2. Curative Care
    • DATA TABLE: Curative Care Market Forecast to 2027(US$ MN)
  • 5.3. Other Usage Patterns
    • DATA TABLE: Other Usage Patterns Market Forecast to 2027(US$ MN)

6. Injectable Drug Delivery Market, By Type

  • 6.1. Formulation
    • DATA TABLE: Formulation Market Forecast to 2027(US$ MN)
    • 6.1.1. Novel Drug Delivery Formulations
    • DATA TABLE: Novel Drug Delivery Formulations Market Forecast to 2027(US$ MN)
      • 6.1.1.1. Long Acting Injection Formulation
      • 6.1.1.2. Microparticles
      • 6.1.1.2.1. Microcapsules
      • 6.1.1.2.2. Microspheres
      • 6.1.1.3. Colloidal Dispersions
      • 6.1.1.3.1. Nanoparticles
      • 6.1.1.3.1.1. Nanosuspensions
      • 6.1.1.3.1.2. Nanoemulsions
      • 6.1.1.3.1.3. Solid-Lipid Nanoparticles
      • 6.1.1.3.2. Polymeric/Mixed Micelles
      • 6.1.1.3.3. Liposomes
      • 6.1.1.3.4. Niosomes
    • 6.1.2. Conventional Drug Delivery Formulations
    • DATA TABLE: Conventional Drug Delivery Formulations Market Forecast to 2027(US$ MN)
      • 6.1.2.1. Suspensions
      • 6.1.2.2. Solutions
      • 6.1.2.3. Reconstituted/Lyophilized Formulations
      • 6.1.2.4. Emulsions
  • 6.2. Device
    • DATA TABLE: Device Market Forecast to 2027(US$ MN)
    • 6.2.1. Self Injection Devices
    • DATA TABLE: Self Injection Devices Market Forecast to 2027(US$ MN)
      • 6.2.1.1. Needle Free Injectors(NFI)
      • 6.2.1.1.1. Technology
      • 6.2.1.1.1.1. Vibration-Based Needle-Free Injectors
      • 6.2.1.1.1.2. Spring-Based Needle-Free Injectors
      • 6.2.1.1.1.3. Laser-Powered Needle-Free Injectors
      • 6.2.1.1.1.4. Jet-Based Needle-Free Injectors
      • 6.2.1.1.2. Product
      • 6.2.1.1.2.1. Prefilled Needle-Free Injectors
      • 6.2.1.1.2.2. Fillable Needle-Free Injectors
      • 6.2.1.1.3. Usability
      • 6.2.1.1.3.1. Disposable Needle-Free Injectors
      • 6.2.1.1.3.2. Reusable Needle-Free Injectors
      • 6.2.1.2. Wearable Injectors
      • 6.2.1.3. Pen Injectors
      • 6.2.1.3.1. Design
      • 6.2.1.3.1.1. Customized Pen Injectors
      • 6.2.1.3.1.2. Standard Pen Injectors
      • 6.2.1.3.2. Product
      • 6.2.1.3.2.1. Dual-Chambered Pen Injectors
      • 6.2.1.3.2.2. Single-Chambered Pen Injectors
      • 6.2.1.3.3. Usability
      • 6.2.1.3.3.1. Disposable Pen Injectors
      • 6.2.1.3.3.2. Reusable Pen Injectors
      • 6.2.1.4. Auto Injectors
      • 6.2.1.4.1. Technology
      • 6.2.1.4.1.1. Manual Autoinjectors
      • 6.2.1.4.1.2. Automated Autoinjectors
      • 6.2.1.4.2. Design
      • 6.2.1.4.2.1. Customized Autoinjectors
      • 6.2.1.4.2.2. Standardized Autoinjectors
      • 6.2.1.4.3. Product
      • 6.2.1.4.3.1. Prefilled Autoinjectors
      • 6.2.1.4.3.2. Fillable Autoinjectors
      • 6.2.1.4.4. Usability
      • 6.2.1.4.4.1. Disposable Autoinjectors
      • 6.2.1.4.4.2. Reusable Autoinjectors
      • 6.2.1.5. Other Devices
    • 6.2.2. Conventional Injection Devices
    • DATA TABLE: Conventional Injection Devices Market Forecast to 2027(US$ MN)
      • 6.2.2.1. Product
      • 6.2.2.1.1. Prefilled Syringes
      • 6.2.2.1.2. Fillable Syringes
      • 6.2.2.2. Material
      • 6.2.2.2.1. Plastic
      • 6.2.2.2.2. Glass
      • 6.2.2.3. Usability
      • 6.2.2.3.1. Disposable Injection Devices
      • 6.2.2.3.2. Reusable Injection Devices

7. Injectable Drug Delivery Market, By Site Of Administration

  • 7.1. Organs
    • DATA TABLE: Organs Market Forecast to 2027(US$ MN)
  • 7.2. Skin
    • DATA TABLE: Skin Market Forecast to 2027(US$ MN)
  • 7.3. Central Nervous System
    • DATA TABLE: Central Nervous System Market Forecast to 2027(US$ MN)
  • 7.4. Circulatory/Musculoskeletal System
    • DATA TABLE: Circulatory/Musculoskeletal System Market Forecast to 2027(US$ MN)

8. Injectable Drug Delivery Market, By Distribution Channel

  • 8.1. Pharmacy Stores
    • DATA TABLE: Pharmacy Stores Market Forecast to 2027(US$ MN)
  • 8.2. Hospital Pharmacy
    • DATA TABLE: Hospital Pharmacy Market Forecast to 2027(US$ MN)
  • 8.3. Online Pharmacy
    • DATA TABLE: Online Pharmacy Market Forecast to 2027(US$ MN)
  • 8.4. Direct Tender
    • DATA TABLE: Direct Tender Market Forecast to 2027(US$ MN)

9. Injectable Drug Delivery Market, By Application

  • 9.1. Orphan Disease
    • DATA TABLE: Orphan Disease Market Forecast to 2027(US$ MN)
  • 9.2. Oncology
    • DATA TABLE: Oncology Market Forecast to 2027(US$ MN)
  • 9.3. Autoimmune Diseases
    • DATA TABLE: Autoimmune Diseases Market Forecast to 2027(US$ MN)
    • 9.3.1. Rheumatoid Arthritis
    • DATA TABLE: Rheumatoid Arthritis Market Forecast to 2027(US$ MN)
    • 9.3.2. Multiple Sclerosis
    • DATA TABLE: Multiple Sclerosis Market Forecast to 2027(US$ MN)
    • 9.3.3. Crohn'S Diseases
    • DATA TABLE: Crohn'S Diseases Market Forecast to 2027(US$ MN)
    • 9.3.4. Psoriasis
    • DATA TABLE: Psoriasis Market Forecast to 2027(US$ MN)
    • 9.3.5. Other Autoimmune Diseases
    • DATA TABLE: Other Autoimmune Diseases Market Forecast to 2027(US$ MN)
  • 9.4. Hormonal Disorder
    • DATA TABLE: Hormonal Disorder Market Forecast to 2027(US$ MN)
    • 9.4.1. Anemia
    • DATA TABLE: Anemia Market Forecast to 2027(US$ MN)
    • 9.4.2. Reproductive Health Disease
    • DATA TABLE: Reproductive Health Disease Market Forecast to 2027(US$ MN)
    • 9.4.3. Antithrombotic/Thrombolytic Therapy
    • DATA TABLE: Antithrombotic/Thrombolytic Therapy Market Forecast to 2027(US$ MN)
    • 9.4.4. Osteoporosis
    • DATA TABLE: Osteoporosis Market Forecast to 2027(US$ MN)
    • 9.4.5. Growth Hormone Disorders(GHD)
    • DATA TABLE: Growth Hormone Disorders(GHD) Market Forecast to 2027(US$ MN)
  • 9.5. Other Applications
    • DATA TABLE: Other Applications Market Forecast to 2027(US$ MN)
    • 9.5.1. Pain Management
    • DATA TABLE: Pain Management Market Forecast to 2027(US$ MN)
    • 9.5.2. Allergy Treatment
    • DATA TABLE: Allergy Treatment Market Forecast to 2027(US$ MN)
    • 9.5.3. Aesthetic Treatments
    • DATA TABLE: Aesthetic Treatments Market Forecast to 2027(US$ MN)
    • 9.5.4. Hepatitis C
    • DATA TABLE: Hepatitis C Market Forecast to 2027(US$ MN)
    • 9.5.5. Hemophilia
    • DATA TABLE: Hemophilia Market Forecast to 2027(US$ MN)

10. Injectable Drug Delivery Market, By End User

  • 10.1. Home Healthcare Settings
    • DATA TABLE: Home Healthcare Settings Market Forecast to 2027(US$ MN)
  • 10.2. Hospitals And Clinics
    • DATA TABLE: Hospitals And Clinics Market Forecast to 2027(US$ MN)
  • 10.3. Pharmaceutical & Biotechnological Companies
    • DATA TABLE: Pharmaceutical & Biotechnological Companies Market Forecast to 2027(US$ MN)
  • 10.4. Research Laboratories
    • DATA TABLE: Research Laboratories Market Forecast to 2027(US$ MN)
  • 10.5. Other End Users
    • DATA TABLE: Other End Users Market Forecast to 2027(US$ MN)

11. Injectable Drug Delivery Market, By Geography

  • 11.1. North America
    • DATA TABLE: North America Market Forecast by Countries to 2027(US$ MN)
    • 11.1.1. US
    • 11.1.2. Canada
    • 11.1.3. Mexico
  • 11.2. Europe
    • DATA TABLE: Europe Market Forecast by Countries to 2027(US$ MN)
    • 11.2.1. Germany
    • 11.2.2. U.K
    • 11.2.3. Italy
    • 11.2.4. France
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia Pacific
    • DATA TABLE: Asia Pacific Market Forecast by Countries to 2027(US$ MN)
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. New Zealand
    • 11.3.6. Rest of Asia Pacific
  • 11.4. Middle East
    • DATA TABLE: Middle East Market Forecast by Countries to 2027(US$ MN)
    • 11.4.1. Saudi Arabia
    • 11.4.2. UAE
    • 11.4.3. Rest of Middle East
  • 11.5. Latin America
    • DATA TABLE: Latin America Market Forecast by Countries to 2027(US$ MN)
    • 11.5.1. Argentina
    • 11.5.2. Brazil
    • 11.5.3. Rest of Latin America
  • 11.6. Rest of the World(RoW)
    • DATA TABLE: RoW Market Forecast by Countries to 2027(US$ MN)
    • 11.6.1. South Africa
    • 11.6.2. Others

12. Key Player Activities

  • 12.1. Acquisitions & Mergers
  • 12.2. Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.3. Product Launch & Expansions
  • 12.4. Other Activities

13. Leading Companies

  • 13.1. Gerresheimer AG
  • 13.2. Baxter International, Inc.
  • 13.3. Pfizer, Inc.
  • 13.4. Alkermes Plc.
  • 13.5. Becton Dickinson and Company
  • 13.6. Eli Lilly and Company
  • 13.7. Schott AG
  • 13.8. Sandoz
  • 13.9. Teva Pharmaceuticals Industries Ltd.
  • 13.10. Bespak
  • 13.11. Ypsomed
  • 13.12. Terumo Corporation
  • 13.13. Elcam Medical
  • 13.14. Unilife Corporation
  • 13.15. Endocyte
  • 13.16. Genentech Inc.
  • 13.17. BIND Biosciences Inc.
Back to Top